Genprex, Roche Collaborate on NSCLC Biomarker Validation
Collaboration Advances Biomarker-Driven Patient Selection and Precision Medicine in Oncology Validation Studies Aim to Optimize Clinical Trial Patient…
Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug
Roche RHHBY reported positive results from the late-stage Krascendo 1 study evaluating experimental candidate, divarasib, in patients with…
Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer
Roche Pharma India has announced the launch of Tecentriq® SC (atezolizumab) in India, introducing the country’s first subcutaneous…
Roche India Launches First Under-the-Skin Lung Cancer Therapy
This new way of giving Tecentriq shows Roche’s focus on improving cancer treatment in India. The faster under-the-skin…
Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancer
Roche Pharma on Thursday launched Tecentriq (atezolizumab), the country’s first subcutaneous immunotherapy for lung cancer — an under-the-skin…